EMAIL DETAILS

Agreed.

Eric D. Schwerin
RSP Investments, LLC
(202) 446-0493
eschwerin@rspinv.com


NOTICE: RSP Investments, LLC is not acting as a municipal advisor and the opinions or views contained herein are not intended to be, and do not constitute, advice within the meaning of Section 975 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. If you have received this communication in error, please destroy all electronic and paper copies and notify the sender immediately. Mistransmission is not intended to waive confidentiality or privilege. RSP Investments, LLC reserves the right, to the extent permitted under applicable law, to monitor electronic communications. By messaging with RSP Investments, LLC you consent to the foregoing.

Sent from my iPhone

> On Jan 20, 2015, at 6:06 PM, Dan McHale <dmchale@rspinv.com> wrote:
>
> He should have gone through me. Emailing the co founder (Brett) is not the proper protocol, nor is sending an unsolicited email that's 5MB when they have a "research inbox" for things like this.
>
> Begin forwarded message:
>
>> From: John DeLoche <john@rstp.com>
>> Date: January 20, 2015 at 5:54:01 PM EST
>> To: bbarth@bbrpartners.com, Todd Whitenack <TWhitenack@bbrpartners.com>, William Page <wpage@bbrpartners.com>
>> Cc: Dan McHale <dmchale@rspinv.com>, Will Lee <will@rstp.com>, Neil Callahan <neil@rstp.com>, "devon@rstp.com" <devon@rstp.com>
>> Subject: RSTP Growth Equity Update
>> Brett, Todd and Will,
>>
>> Happy New Year from the RSTP Team! Lots of good news to share as RSTP finished an active 2014 by leading the first institutional investment round in Metabiota, a profitable software and services company that is the world leader in capturing, analyzing, preventing and insuring against microbial threats. Attached is recent Metabiota press from Wall Street Journal: http://www.rstp.com/nathan-wolfe-hunt-new-viruses/
>>
>> More portfolio company news with Counsyl, a company completely disrupting the Lab Testing market through software and robotics, had a record year with both number of completed tests and revenue. They are on target and now in the process of preparing for an IPO. Attached is recent Counsyl press from the Wall Street Journal:http://www.rstp.com/counsyl-new-genetic-tests/
>>
>> RSTP will hold rolling closings in the coming months as we move toward our final June closing of RSTP II, LP. We will be calling to schedule a time to follow up with you to discuss our portfolio, pipeline and a partnership between our firms over dinner or a meeting. Attached is our updated RSTP Overview Presentation.
>>
>> Best regards,
>>
>> The RSTP Team
>>
>> John, Will, Neil and Devon
>>
>> John DeLoche
>> Co-founder & Managing Director
>> RSTP
>> 333 Bush Street, 21st Floor
>> San Francisco, CA 94104
>> direct: 415 767 1288
>> mobile: 415 793 7070
>>
>>
>> <Confidential RSTP Overview.pdf